Abstract
AbstractN-acetyl cysteine (NAC) is a potential pharmacotherapy for alcohol use disorder (AUD), but it is not known whether it modulates neural activation to alcohol cues or intrinsic functional connectivity. We investigated whether NAC attenuates i) alcohol cue-elicited activation, and ii) intrinsic functional connectivity compared to placebo in patients with AUD. Twenty-three individuals (7 females) with moderate-severe AUD received daily NAC (2400 mg/day,n= 9), or a placebo (n= 14) for at least 2 weeks. Participants completed a pre-treatment functional magnetic resonance imaging session (T0) and a post-treatment session (T1) comprising a resting-state and visual alcohol cue reactivity task acquisitions. Activation differences between sessions, treatment, and session-by-treatment interaction were assessed. Resting-state functional connectivity examined using 376 node ROI-to-ROIs evaluated whether NAC reduced intrinsic functional connectivity after treatment. There were no differences in alcohol cue reactivity for brain activation or subjective craving between NAC and placebo during treatment or across sessions, or significant interaction. A significant treatment-by- time interaction, with reduced intrinsic connectivity was observed after treatment (T1) for NAC- treated compared to placebo-treated patients in the posterior cingulate node (9, left hemisphere) of the dorsal attentional network and connections to salience, ventral-attentional, somatosensory, and visual-peripheral networks implicated in AUD. NAC reduced intrinsic functional connectivity in patients with moderate-severe AUD after treatment compared to placebo, but did not attenuate alcohol cue-elicited activation. The reduced intrinsic functional connectivity pattern seen may signify reduced external processing of environmental alcohol cues, though no reduced visual cue reactivity associations were evidenced.
Publisher
Cold Spring Harbor Laboratory